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http:WHAT THIS PAPER ADDS
This study, collecting the largest number of endovascular procedures performed in popliteal artery aneurysms
(PAAs), demonstrates that a careful analysis of the patient’s and lesion’s characteristics allows us to choose the
right therapeutic approach providing excellent early and long-term results.Introduction: The aim of this study was to analyse early and follow-up results of the treatment of popliteal artery
aneurysms (PAAs) performed with open surgical repair or with endovascular exclusion with endografts in
a multicentric retrospective registry involving seven Italian vascular centres.
Materials and methods: We retrospectively collected data concerning 178 open surgical interventions (OR
group) and 134 endovascular exclusions (ER group) for PAAs performed between January 2000 and December
2011. Early and follow-up results were analysed in terms of mortality, graft patency, reintervention and limb
preservation.
Results: OR patients were more frequently symptomatic (64%, 115 cases) than patients in the ER group (34%, 51
cases; p < 0.001), had more frequently acute limb ischaemia (23% and 6.5%, respectively; p < 0.001) and had
more frequently a run-off score <2 (39% and 26%, respectively, p ¼ 0.03). In the OR group there were no
perioperative deaths; six thromboses (3.3%) and one amputation occurred. In the ER group mortality was 1.5%;
13 thromboses (9.7%) and one amputation (0.5%) occurred. Mean duration of follow-up was 30.6  27.5
months. In the OR group primary and secondary patency, freedom from reintervention and limb preservation
rates at 48 months were 63.5% (standard error (SE) 0.05), 76.5% (SE 0.05), 72.5% (SE 0.06) and 89.7% (SE 0.05),
respectively. The corresponding ﬁgures in the ER group were 73.4% (SE 0.04), 85% (SE 0.04), 75% (SE 0.04) and
97% (SE 0.04), respectively.
Conclusions: In this large multicentric retrospective registry, open and endovascular treatment of PAAs are used
in different patients with regard to clinical and anatomical characteristics. Both treatments are feasible and safe,
providing satisfactory early and long-term results.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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localisation of arterial aneurysms.1 Complicated popliteal
artery aneurysm (PAA) can cause rupture, distal embolisa-
tion and thrombosis, leading to high risk of limb loss. For
this reason, elective surgical management of asymptomatic
aneurysms larger than 20 mm is currently recommended.2rresponding author.
il addresses: dorigow@uniﬁ.it, dorigow@email.com (W. Dorigo).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.01.012Open surgical repair provides very satisfactory results,
particularly in the elective setting, and high rates of graft
patency and freedom from amputation during follow-up
have been reported.1e3 In recent years, PAA exclusion
with stent graft has been emerging as a possible alter-
native to open surgery, particularly in high-surgical-risk
patients.4e6
There are however few reports in the literature
comparing traditional open repair (OR) to the endovascular
(ER) approach and single-centre experiences provide only
small series of patients with limited statistical power.7e11
The aim of this study was to retrospectively review the
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endovascular repair of PAAs in a large multicentric registry
involving seven Italian vascular centres.MATERIALS AND METHODS
From January 2000 to December 2011, 312 open and
endovascular interventions for PAA were performed in
seven Italian hospitals, in 178 cases with conventional OR
and in 134 cases with an ER procedure. The results of one
of the participating centres have been recently
published.11
Data from all the interventions were retrospectively
collected in a dedicated database, which included demo-
graphic data, preoperative risk factors, clinical and diag-
nostic assessment, intra-operative features and early and
follow-up outcomes.
Risk factors and co-morbidities included arterial hyper-
tension (deﬁned as blood pressure >130/85 mmHg or the
need for anti-hypertensive drugs), hyperlipaemia (deﬁned
as triglycerides and cholesterol values >200 mg dl1),
coronary artery disease (history of myocardial infarction,
angina and previous coronary revascularisation), diabetes
mellitus (deﬁned as the need for speciﬁc drugs to maintain
metabolic control) and chronic obstructive pulmonary
disease (COPD; deﬁned as a forced expiratory volume in 1 s
(FEV1) <70%).
All patients underwent Duplex examination and angio
computed tomography (CT) scan or digital subtraction
angiography (DSA) before surgery. The indication for treat-
ing asymptomatic aneurysm was a diameter >20 mm. In
symptomatic patients indication for surgery was unrelated
to aneurysms’ diameter.
While in the ﬁrst years the indication for ER was the
presence of a focal PAA with at least two patent tibial
vessels, nowadays also longer lesions are evaluated for
endovascular intervention, provided a proximal and distal
landing zone of at least 2 cm length is present, with the
patency of at least one tibial vessel. All ER procedures were
carried out in the operating room.
In selected patients with mild-to-moderate ischaemia
(grade I or IIa according to Rutherford’s classiﬁcation of
acute ischaemia) due to acute aneurysms’ thrombosis,
preoperative catheter-directed thrombolysis with urokinase
was performed.
Thrombolytic treatment was administered in a bolus of
100,000 I.U., followed by continuous infusion with
a delivery rate of 70,000e100,000 I.U. h1 on the basis of
the patient’s characteristics and surgeon’s habits. Throm-
bolysis was deﬁned successful in the presence of restored
patency of the popliteal artery and at least one tibial vessel.
Surgical intervention was performed within a few days from
the cessation of administration of thrombolytic treatment.
In the case of unsuccessful thrombolysis a prompt surgical
attempt was performed. All the patients underwent
systemic heparinisation during thrombolysis; the route of
administration and the dose of heparin were at surgeon’s
discretion on the basis of institutional habits. Patientspresenting with grade IIb or worse ischaemia underwent
prompt open surgical repair.
Demographic, clinical and anatomical characteristics of
the two treatment groups were compared with the chi-
squared test.
The surveillance programme consisted of clinical and
ultrasonographic examinations at 1, 6 and 12 months and
yearly thereafter. Patency of the graft and status of anas-
tomoses, of inﬂow and outﬂow vessels and of the contra-
lateral femoro-popliteal axis were assessed. In patients who
had undergone ER treatment, also the exclusion of the
aneurysmal sac from the blood ﬂow was examined.
Due to the signiﬁcant clinical and anatomical differences
between patients treated with open and endovascular
repair, which made a direct comparison not reliable, we
reported the early and late outcomes of the two treatment
strategies without comparing them.
Early (<30 days) results were analysed in terms of
mortality, graft thrombosis and amputation rates. Incom-
plete data concerning hospital length of stay were recorded
and the mean values for the collected data were analysed.
Follow-up results (survival, primary and secondary
patency, freedom from amputation and freedom from
reintervention) were analysed by KaplaneMeier curves.
Data were reported at the maximum time frame with
a standard error (SE) <0.10.
Primary patency was deﬁned as uninterrupted patency
without procedures performed on or at the margin of the
treated segment, whereas secondary patency was deﬁned
as restored patency through the original treated segment.
Freedom from amputation was deﬁned as the avoidance of
above- or below-knee amputation, while freedom from
reinterventions was deﬁned as the avoidance of any open
or endovascular new procedure on the treated artery.
Univariate analysis for primary patency during follow-up
in the whole study group was performed; multivariate
analysis (Cox regression) for factors that resulted signiﬁcant
at univariate analysis was performed, as well. Statistical
signiﬁcance was deﬁned as a p value <0.05.
Statistical analysis was performed with a dedicated soft-
ware for Windows (Statistical Package for Social Sciences,
SPSS Inc., Chicago, IL, USA).RESULTS
Demographic data, clinical and anatomical status
Main demographic, clinical and anatomical characteristics in
the two groups of patients are listed in Table 1. There were
no differences between the two groups in terms of gender,
risk factors for atherosclerosis and co-morbidities; there
was a trend towards older age at the time of intervention in
the ER group than in the OR group. There were signiﬁcant
differences between the two groups in terms of clinical
presentation; also, the status of run-off was different
between the two groups. Mean diameter of the treated
lesion was 33.5 mm in OR patients and 34.7 mm in ER
patients (p ¼ 0.2).
Table 1. Demographic data, clinical and anatomical characteristics.
Open group
(178 cases)
Endo group
(134 cases)
p
Male gender 13 (7.5%) 13 (9.5%) 0.4
Mean age 70  8.9 yrs. 74.9  7.9 yrs. 0.06
Smoker or past
smoker
98 (55%) 94 (70%) 0.07
Coronary artery
disease
61 (34%) 41 (30.5%) 0.3
Arterial hypertension 142 (80%) 93 (70%) 0.08
Hyperlipaemia 60 (33.5%) 46 (34%) 0.7
Diabetes 37 (20.5%) 28 (21%) 0.8
COPD 45 (25%) 31 (23%) 0.7
Asymptomatic PAA 63 (35.5%) 82 (71%) <0.001
Symptomatic PAA 115 (64.5%) 52 (29%) <0.001
Claudication 42 32
Rest pain 32 9
Acute ischaemia 41 10
Rupture e 1
Run off score <2 67 (37.5%) 31 (23%) 0.007
Other aneurysms 42 (23.5%) 16 (13.5%) <0.001
Aorto-iliac 35 5
Renal 2 e
Splenic 2 e
Axillary 1 e
Contralateral
femoral
1 e
Cerebral 1 e
R. Pulli et al. 359In 126 cases contralateral PAA was present (68 in OR
patients and 58 in ER patients). Other aneurysms were
present in 58 cases (18.5%), 42 in the OR group (23.5%) and
16 in the ER group (13.5%, p < 0.001), whose locations are
detailed in Table 1. Twenty-two patients (7 in the OR group
and 15 in the ER group) had been previously operated on
for abdominal aortic aneurysm.
Acute ischaemia and rupture
Forty patients with mild-to-moderate acute ischaemia due
to PAA thrombosis underwent preoperative intra-arterial
thrombolysis, 30 among the OR patients (17%) and 10 ER
patients (7.5%; p ¼ 0.07, odds ratio (OR) 0.2, 95% conﬁ-
dence interval (CI) 0.04e1.1). Eleven patients with grade IIb
ischaemia underwent prompt OR. The mean duration of
thrombolytic treatment was 64.5  46.5 h in OR patients
and 48.6  34.4 h in ER patients. Thrombolysis was
successful in 18 out of the 30 patients in the OR group and
in 9 patients of the ER group. The remaining patient of the
ER group had complete recanalisation of PAA but only
partial recanalisation of tibial vessels.
Five major complications (11.5%) occurred during
thrombolysis. Among the OR patients, one developed
a severe (>50,000) thrombocytopaenia, requiring the
cessation of thrombolytic drug and of heparin, while
another patient suffered from a contralateral femoral
pseudo-aneurysm, requiring surgical repair during the same
intervention for the treatment of the PAA. One further
patient had a sudden increase of the aneurysm’s diameter
during thrombolysis, with compartment syndrome,requiring immediate surgical intervention. In the ER group,
two contralateral femoral pseudo-aneurysms requiring
surgical repair occurred.
In one case of a patient with known PAA presenting
with severe pain of the affected leg, a contained rupture of
a large (5  6 cm) PAA was present at preoperative CT
scan, and this case was treated with an urgent ER
procedure.12
Operative details
In the OR group, 13 cases were treated with aneur-
ysmectomy and graft interposition (in 11 cases with pros-
thetic graft and in 2 cases with an autologous saphenous
vein), while in 73 cases the aneurysm was opened and
a graft (an autologous saphenous vein in 48 cases and
a prosthetic graft in 25 cases) was placed inside the aneu-
rysm in a fashion similar to that used to repair aortic
aneurysms. In 92 cases, proximal and distal ligation of the
aneurysm with bypass grafting (76 with a prosthetic graft
and 16 with an autologous vein) was carried out. A medial
approach was used in 139 cases (78%) and a posterior
approach was used in 39 cases. In 111 interventions, the
inﬂow vessels were the common or the superﬁcial femoral
artery and in the remaining 67 it was the above-knee
popliteal artery. The outﬂow vessel was in most cases the
below-knee popliteal artery (152 cases, 85%), while in 26
cases it was the tibioperoneal trunk or a tibial vessel.
Associated interventions at the distal anastomotic site were
performed in 13 cases (vein cuff in four cases, patching in
four cases, arterio-venous ﬁstula in three patients and tibial
angioplasty in the remaining two). Two adjunctive patients
had common-to-deep femoral artery short bypass for
concomitant involvement of common or deep femoral
arteries, while another patient had ipsilateral iliac angio-
plasty for improving the inﬂow.
In this group, all the patients had intra-operative
administration of 30e50 I.U. kg1 of intravenous heparin at
arterial clamping.
Postoperative and long-term medical treatment consisted
of single anti-platelet therapy in 78 cases, of double anti-
platelet therapy in 64 cases and of oral anticoagulants in 36
patients, the regimen for anticoagulation or anti-platelet
being determined just on the basis of the surgeon’s pref-
erences and habits.
In the ER group, all the patients had endoprosthesis
placement (Hemobahn or Viabahn, W.L. Gore & Associates
Inc, Flagstaff, AZ, USA).
In 92 cases an ipsilateral surgical femoral approach was
used, while 39 patients had ipsilateral percutaneous access;
in three cases contralateral femoral access was used. Inﬂow
vessels were the superﬁcial femoral artery in 119 cases and
the proximal popliteal artery in 15 cases; the outﬂow vessel
was in all but two cases the proximal and the middle
popliteal artery (P1 in 78 cases and P2 in 54 cases), while in
the remaining patients it was the distal popliteal/tibio-
peroneal trunk.
The mean number of placed stents was 2 (range 1e7),
with a mean length of 200 mm (range 100e350). Adjunctive
Figure 1. KaplaneMeier curves for primary patency with numbers
of patients at risk and standard error values at 48 months.
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cases.
All these patients had intravenous administration of
5000 I.U. of sodium heparin at the beginning of the
procedure. Postoperative and long-term medical treatment
consisted of double anti-platelet therapy in all the cases.
Perioperative (<30 days) results in OR patients
No perioperative deaths occurred. There were six throm-
boses (3.3%), four of them occurring in patients with acute
limb ischaemia (p < 0.001 in comparison with patients
without acute presentation); these patients were success-
fully treated in three cases (with thrombolysis and stenting
of distal anastomosis in two cases and with surgical
thrombectomy in one), while in the other three cases (all
acute ischaemia) major amputation was unavoidable
despite a new surgical attempt (cumulative amputation rate
1.6%; amputation rate in acute patients 7.5%). Three
adjunctive early reinterventions were required due to
signiﬁcant bleeding at anastomotic sites (reintervention rate
5%). Mean length of stay in 115 out of 178 patients was
10.4 days (range 4e45).
Perioperative (<30 days) results in ER patients
Technical success occurred in all the cases.
There were two perioperative deaths (mortality rate
1.5%); one patient who had undergone concomitant
endovascular aneurysm repair (EVAR) and PAA endografting
developed in the ﬁrst postoperative day an acute throm-
bosis of popliteal endografting, which required conversion
to below-knee femoro-popliteal bypass, followed by major
amputation due to graft occlusion. During the postoperative
course in the intensive care unit (ICU), the patient suffered
from a fatal, acute myocardial infarction. Another patient
suffered from fatal cerebral haemorrhage in the fourth
postoperative day, although he had not undergone throm-
bolytic treatment.
Thirteen 30-day thromboses occurred (9.7%), in one case
in a patient with acute presentation; in all the cases rein-
tervention was performed, in one patient leading to major
amputation (cumulative amputation rate 0.5%; no ampu-
tation in acute patients). The rate of early reinterventions
was 9.7%. Mean length of stay in 64 out of 134 patients was
6.4 days (range 2e17).
Follow-up results in OR group
Follow-up was available in 168 interventions (94.5%) with
a mean follow-up time of 27 months (range 1e156). In this
period there were ﬁve new deaths; the cause of death was
cardiac in three patients, while one patient died from
cancer. In one case the cause of death was unknown. Esti-
mated survival rates at 12, 24 and 48 months were 99.2%
(SE 0.008), 97.2% (SE 0.016) and 95.7% (SE 0.05), respec-
tively. Thirty-six new thromboses occurred; estimated
primary patency rates at 12, 24 and 48 months were 78.8%
(SE 0.03), 77.1% (0.03) and 63.4% (SE 0.05), respectively
(Fig. 1).Primary patency rates at 4 years were signiﬁcantly better
in patients operated on with an autologous vein (86.3%, SE
0.05) than in patients who had a prosthetic graft (56.3%, SE
0.06; p ¼ 0.01); there was a trend towards better primary
patency rates in patients with the posterior approach
than in patients with the medial approach (p ¼ 0.07, log
rank 3.2).
In patients with thrombosis, a reintervention was per-
formed in 23 cases; nine of the 13 remaining patients had
graft thrombosis without critical ischaemia and were
medically managed, while in the other four cases major
amputation was unavoidable.
Freedom from reintervention rates at 12, 24 and 48
months were 87% (SE 0.28), 86.1% (SE 0.03) and 72.5% (SE
0.06), respectively; estimated secondary patency rates at
the same time intervals were 84.7% (SE 0.03), 82.7% (SE
0.032) and 76.5% (SE 0.05) (Fig. 2).
Recurrent thrombosis despite reintervention occurred in
12 patients, leading to ﬁve major amputations.
The rates of limb salvage at 12, 24 and 48 months were
94.3% (SE 0.02), 92.6% (0.022) and 89.7% (SE 0.05),
respectively.
The rate of limb salvage at 48 months in patients with
acute ischaemia was 81.5% (SE 0.07).Follow-up results in ER group
Follow-up was available in 128 interventions (95.5%), with
a mean follow-up time of 35 months (range 1e124).
Twenty-one deaths occurred: the cause of death was cancer
in two patients, while another patient died from cardiac
Figure 2. KaplaneMeier curves for freedom from reintervention
with numbers of patients at risk and standard error values at 48
months.
R. Pulli et al. 361disease. In two cases rupture of thoracic aortic aneurysm
occurred, while two patients had a fatal stroke and one
patient died from pulmonary embolism. The cause of death
was unknown in 12 cases.
Estimated survival rates at 12, 24 and 48 months were
91.1% (SE 0.027), 87.3% (SE 0.034) and 83.9% (SE 0.04),
respectively. There were 14 new thromboses; estimated
primary patency rates at 12, 24 and 48 months were 79.1%
(0.037), 76.9% (SE 0.04) and 73.4% (SE 0.05) (Fig. 1).
In patients with thrombosis, reintervention was per-
formed in 12 cases; the two remaining patients developed
mild claudication and they were medically managed.
Freedom from reintervention rates at 12, 24 and 48 months
were 80.6 (SE 0.034), 77.2% (SE 0.04), and 75% (SE 0.04),
respectively. Estimated secondary patency rates at the same
time intervals were 90.8% (SE 0.027), 85.5% (SE 0.035) andTable 2. Univariate and multivariate (for signiﬁcant factors at univariate
group.
Univariate analysis
Log-rank p
Female gender 0.2 0.6
Diabetes 0.7 0.5
Symptomatic PAA 11.3 0.001
Limb-threatening ischaemia 4.6 0.03
Run-off score 0e1 15.2 <0.001
Preoperative thrombolysis 3.1 0.08
Endovascular intervention 0.4 0.6
Adjunctive distal procedure 11.6 0.00185% (SE 0.04), respectively (Fig. 2). Recurrent thrombosis
despite reintervention occurred in seven patients leading to
three major amputations.
The rates of limb salvage at 12, 24 and 48 months were
98.1% (SE 0.013), 96.9% (0.04) and 96.9% (SE 0.04),
respectively. The four-year limb salvage rate in patients with
acute ischaemia was 87.5% (SE 0.09).
In one patient a type II endoleak from a large genicular
artery was noted at 12 months, with a slight increase
(<5 mm) in sac diameter with respect to preoperative
value; a conservative approach was decided in this case,
which is still under surveillance.
Univariate analysis in the whole group of 312 interven-
tions showed that aneurysmal preoperative symptoms,
limb-threatening ischaemia a poor run-off status and the
need for adjunctive distal procedures signiﬁcantly affected
primary patency during follow-up; at multivariate analysis
preoperative symptoms, poor run-off status and the use of
distal procedures maintained their signiﬁcance (Table 2).DISCUSSION
Although traditional surgical repair is still considered the
gold standard in the treatment of PAA, the ER approach has
been gaining popularity and interest, due to the easy
deployment of stent grafts and to the low invasiveness of
the procedure. As a consequence, a great deal of papers on
this issue have been published in recent years.4e11
However, at the moment, only a shorter length of hospi-
talisation in endovascularly managed patients has been
reported in the few papers comparing the two treat-
ments.7e11 Furthermore, the very limited number of
patients collected in these single-centre comparisons did
not allow the authors to draw any consistent conclusions.
Antonello and colleagues7 compared in a randomised
study the results of 15 ORs with those of 15 ER procedures
performed in asymptomatic PAAs with good run-off status
and found no signiﬁcant differences between the two
options at 12-month follow-up, with some advantages for
ER in terms of operative time and hospital stay. The same
authors updated their study9 and they did not still ﬁnd any
differences in terms of primary and secondary patency at 72
months, with a 14% rate of late conversion to open surgery.
Curi and colleagues10 retrospectively reviewed their
results in 15 endovascular PAA repairs compared with 41) analysis for primary patency during follow-up in the whole study
Multivariate analysis
95% CI OR 95% CI OR p
0.3e2 0.8
0.5e1.9 1
1.3e3.6 2.2 1.1e3.2 1.9 0.02
0.3e0.9 0.5 0.4e2.2 1.1 0.08
1.5e3.8 2.4 1.1e3.2 1.9 0.01
0.3e1 0.6
0.5e1.3 0.8
1.5e5.4 2.8 1e3.9 2 0.04
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ER treatment was performed mainly in asymptomatic
patients (13 cases, 87%) and all acute PAA thromboses were
treated with open intervention. Estimated 24-month curves
were similar between the two techniques, with 83% and
100% of primary and secondary patency for ER treatment.
Stone and colleagues8 reported seven cases of ER treat-
ment, performed in all but one case in asymptomatic
patients, and 48 open interventions; even if the study was
not mainly designed to compare the outcomes of the two
procedures, two out of the seven endografts thrombosed
during follow-up, while graft thrombosis occurred only in
two patients who had undergone OR. However, the need
for secondary procedures to maintain the patency of the
graft was signiﬁcantly higher in the open surgery group.
In spite of these encouraging outcomes, Lovegrove et al.13
in their meta-analysis did not justify a shift towards an ER
treatment and in a more recent paper Cina14 concludes that
a randomised controlled trial (RCT) is necessary to deﬁne the
true role of this new modality of treatment for PAAs.
However, in the scientiﬁc community it is well known how
difﬁcult is the planning of a RCT and often the registries
better reﬂect the so-called daily practice.
In this paper we collected data from seven Italian
hospitals in the attempt to accomplish a large data set for
analysing early and intermediate results of ER treatment of
PAAs and we reported the results obtained with OR in the
same period of time.
In our experience, the indications to open and endovas-
cular treatment were signiﬁcantly different: open surgery
was preferred in symptomatic aneurysms, with complex
anatomical features and often in the presence of acute or
limb-threatening ischaemia. However, it must be underlined
that in the present study we collected a percentage of
symptomatic PAAs endovascularly treated that is largely
higher (29%) than in previous papers; in addition, about
one-quarter of the patients of the ER group had only one
patent distal vessel.
As the two groups were not homogeneous under a clin-
ical and anatomical point of view, we preferred anyway not
to perform a direct comparison between the two treatment
strategies.
The outcome of OR remains good in both symptomatic
and asymptomatic patients, conﬁrming the results of
previous studies, even in the presence of a higher
percentage of interventions performed with a prosthetic
graft rather than with an autologous vein. It has been
clearly demonstrated that the vein graft offers an advantage
in terms of early and late results in patients with PAA,2,15,16
and this was also in our experience, suggesting that an
autologous vein can be considered the material of choice in
OR patients. The relevant percentage of expanded poly-
tetraﬂuoroethylene (ePTFE) bypasses in the present series is
probably due to the good performance of this kind of graft
in patients with obstructive femoro-popliteal disease in the
experience of the participating centres.17 Moreover, about
60% of our patients had more than one patent tibial vessel,
and this fact could have contributed to the choice ofpreserving the autologous vein for further revascularisa-
tions. We found a trend towards better results in OR
patients who had a posterior approach, and this result had
been already underlined in the series of one of the
participating centres.3
Only clinical and anatomical complexities of the lesions
seem to signiﬁcantly affect late failure in our experience.
We found a higher percentage of early reinterventions in
the ER group and a higher limb salvage rates during follow-
up, again in the ER group. These results seem in contrast,
but the possible explanation is that early reinterventions
often consisted of a new endovascular adjustment and they
did not inﬂuence the long-term outcomes. In addition, at
uni- and multi-variate analyses the ER approach did not
represent an adjunctive risk factor. The risk of developing an
endoleak is low in our experience and probably it does not
represent the main complication of ER of PAAs.
In our endovascular series there were about 10% of
patients with acutely thrombosed PAAs that represented in
previous reports an exclusion criterion for endografting. The
use of intra-arterial thrombolysis in selected patients with
moderate ischaemia allowed us to achieve satisfactory
results; once the patency of the popliteal artery and tibial
vessels is restored, a choice between open and ER on the basis
of clinical and anatomical consideration is requested.18e20
This study has several limitations: it is a retrospective
non-randomised study, with several discrepancies between
open and endovascular groups in terms of clinical presen-
tation and of run-off status, a relatively short period of
follow-up and a low number of events. Moreover, due to its
retrospective nature, some data are missing or not
complete. On the other hand, in our opinion its strength lies
in the signiﬁcant number of collected endovascular inter-
ventions, which makes it the largest report on this topic at
the moment, and in the representation of the current
attitude towards this disease in the daily practice.
CONCLUSIONS
In this large multicentric retrospective registry, open and
endovascular treatment of PAAs was used in different
patients with regard to clinical and anatomical characteris-
tics. If a careful analysis of the patient’s and lesion’s char-
acteristics is performed in choosing the right therapeutic
approach, early and long term results are satisfactory. An
RCT comparing the two treatment options is warranted.CONFLICT OF INTEREST/FUNDING
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